Long-term Study to Evaluate Safety and Persistence of GF-CART01

Clinical trial NCT06985576 · ENROLLING_BY_INVITATION

Trial details

NCT number: NCT06985576
Sponsor: GenomeFrontier Therapeutics TW Co., Ltd.
Status: ENROLLING_BY_INVITATION
Study type: OBSERVATIONAL

DLBCL - Diffuse Large B Cell Lymphoma Follicular Lymphoma (FL)Primary Mediastinal Large B-Cell Lymphoma High Grade B Cell Lymphoma

Start date: 2026-02-26
Primary completion: 2041-05-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.